SUMO Promotes DNA Repair Protein Collaboration to Support Alterative Telomere Lengthening in the Absence of PML
Rongwei ZhaoiD, Meng Kai XuiD, Anne R. Wondisford, Rachel M. LackneriD, Jayme SalsmaniD, Graham DellaireiD, David M. ChenowethiD, Roderick J. O’SullivaniD, Xiaolan ZhaoiD, Huaiying ZhangiD
Abstract
Alternative lengthening of telomeres (ALT) pathway maintains telomeres in a significant fraction of cancers associated with poor clinical outcomes. A better understanding of ALT mechanisms can provide a basis for developing new treatment strategies for ALT cancers. SUMO modification of telomere proteins plays a critical role in the formation of ALT telomere-associated PML bodies (APBs), where telomeres are clustered and DNA repair proteins are enriched to promote homology-directed telomere DNA synthesis in ALT. However, whether and how SUMO contributes to ALT beyond APB formation remains elusive. Here, we report that SUMO promotes collaboration among DNA repair proteins to achieve APB-independent telomere maintenance. By using ALT cancer cells with PML protein knocked out and thus devoid of APBs, we show that sumoylation is required for manifesting ALT features, including telomere clustering and telomeric DNA synthesis, independent of PML and APBs. Further, small molecule-induced telomere targeting of SUMO produces signatures of phase separation and ALT features in PML null cells in a manner depending on both sumoylation and SUMO interaction with SUMO interaction motifs (SIMs). Mechanistically, SUMO-induced effects are linked to the enrichment of DNA repair proteins, including Rad52, Rad51AP1, and BLM, to the SUMO-containing telomere foci. Finally, we find that Rad52 can undergo phase separation, enrich SUMO on telomeres, and promote telomere DNA synthesis in collaboration with the BLM helicase in a SUMO-dependent manner. Collectively, our findings suggest that, in addition to forming APBs, SUMO also promotes collaboration among DNA repair proteins to support telomere maintenance in ALT cells. Given the promising effects of sumoylation inhibitors in cancer treatment, our findings suggest their potential use in perturbing telomere maintenance in ALT cancer cells.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 5
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Telomeric SUMO level influences the choices of APB formation pathways and ALT efficiency
Rongwei Zhao, Xiaoyang Yu, … Huaiying Zhang·The Journal of Cell BiologyPeer-reviewed·Jun 10, 2025
- Liquid condensation drives telomere clustering during ALT
H. Zhang, M. Liu, … M. A. Lampson·bioRxiv·May 9, 2019
- Telomere length heterogeneity in ALT cells is maintained by PML-dependent localization of the BTR complex to telomeres
T. K. Loe, J. Li, … E. Lazzerini Denchi·Genes & DevelopmentPeer-reviewed·Mar 26, 2020
- Histone demethylase KDM2A is a selective vulnerability of cancers relying on alternative telomere maintenance
- Orphan nuclear receptors promote alternative lengthening of telomeres (ALT) through ALT-associated PML bodies
Venus Marie Gaela, Hsuan-Yu Hsia, … Liuh‐Yow Chen·bioRxiv·Mar 30, 2022
- Human PC4 supports telomere stability and viability in cells utilizing the alternative lengthening of telomeres mechanism
Sara Salgado, Patrícia L. Abreu, … Claus M. Azzalin·EMBO ReportsPeer-reviewed·Oct 28, 2024